Gold Nanodots Boost Ultrasound Cancer Treatment

Recent advancements in nanotechnology have opened up promising avenues in the field of cancer treatment. One such development involves the use of gold nanodots to enhance the effectiveness of ultrasound therapy in inducing cancer cell death. A study conducted by researchers at the Department of Bioengineering (BE), Indian Institute of Science (IISc), explores how manipulating the spacing of integrin-ECM (extracellular matrix) binding domains can significantly influence cancer treatment outcomes.

The Role of Integrins and ECM in Cancer Treatment

Integrins are transmembrane receptors that facilitate cell adhesion to the ECM, which is critical for cell growth and migration. Understanding the interaction between integrins and their binding sites on the ECM is foundational to improving cancer therapies. In healthy tissues, the natural spacing of these binding domains is typically between 50–70 nanometers (nm). However, in cancerous tissues, abnormal ECM secretion can compress this spacing to below 50 nm, thus hampering effective treatment.

According to Ajay Tijore, an Assistant Professor in BE and the corresponding author of the study published in Nano Letters, "We found more cancer cells being killed when the binding spacing was increased to around 50–70 nm." This indicates a direct correlation between the spacing of ECM binding domains and the susceptibility of cancer cells to ultrasound treatment.

Ultrasound Treatment Explained

Ultrasound therapy employs low-frequency sound waves (approximately 39 kHz) that can disrupt cellular membranes, specifically targeting cancerous cells. Unlike normal cells, which possess repair mechanisms, cancer cells are less able to withstand such disruptions. The team devised an experiment wherein they constructed an array of gold nanodots with variable spacing (35 nm, 50 nm, and 70 nm) and analyzed how invasive cancer cells reacted to pulsed ultrasound waves applied to these models.

Mechanism of Action

Upon applying ultrasound to cancer cells bound to gold nanodots spaced at 50 nm and 70 nm, it was observed that the cell membranes stretch due to forces generated by myosin, a filamentous protein. This mechanical deformation leads to the influx of extracellular calcium into the cytoplasm, causing mitochondrial damage and ultimately triggering apoptosis (programmed cell death).

“Just like how we touch a surface to feel the texture, cancer cells need to 'pinch' the ECM by applying myosin forces to sense the ECM architecture,” - Ajay Tijore.

Innovative Drug Combination

A fascinating aspect of this study was the investigation into a drug called cilengitide, historically known for its ineffectiveness in clinical trials. Interestingly, when used at a low dose (approximately 1,000 times lower than initially tested), cilengitide appears to alter cancer cell perception of ECM spacing. Tijore explains, “We are fooling the cancer cell into thinking that the 35 nm spacing has increased. Now the cell starts developing myosin forces, pumping more calcium inside, and this triggers cancer cell killing.”

Current Research Focus

The researchers are currently collaborating with clinicians to investigate this treatment approach on oral cancer tissue samples. Given the high prevalence of oral cancers in the Indian subcontinent and the associated challenges of excessive ECM deposition, this research could provide a revolutionary method to enhance treatment efficacy while minimizing side effects.

Conclusion

The study highlights a novel approach wherein gold nanodots and adjustments in integrin-ECM binding can synergistically enhance the efficacy of ultrasound treatment in cancer therapy. As research progresses, the focus on integrating nanotechnology with existing treatment modalities holds promise for achieving better patient outcomes.

References

Veena, S. M., et al. (2025). Nanoscale ligand spacing regulates mechanical force-induced cancer cell killing. Nano Letters. DOI: 10.1021/acs.nanolett.4c05858.

For further information, visit Science X.